Last update:
Medications
Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.
Sep 17, 2020
0
22
HIV & AIDS
For Black women in the southern United States, mistrust of the health care system that is grounded in structural and systemic racism is a key factor affecting participation in HIV prevention and treatment services, reports ...
Sep 17, 2020
0
5
As the HIV epidemic enters its fourth decade, men who have sex with men (MSM) make up a disproportionate number of new HIV diagnoses in the United States. A report from the CDC revealed that MSM represented nearly 70 percent ...
Sep 16, 2020
0
4
The newer generation of HIV drugs have turned the once-lethal infection into a chronic condition, and cardiovascular disease has emerged as the leading cause of death in these individuals.
Sep 16, 2020
0
6
As COVID-19 swept through the South, Mel Prince watched with alarm as some of the HIV positive patients she helps in the rural Black Belt stopped showing up for lab tests and doctor's visits.
Sep 14, 2020
0
3
World Health Organization-recommended campaigns to circumcise millions of African boys and men to reduce HIV transmission are based more on systemic racism and 'neocolonialism' than sound scientific research, according to ...
Sep 10, 2020
0
13
In France, antiretroviral treatment (ARV) can be dispensed by hospitals and/or community pharmacies. A recent study published in Pharmacology Research & Perspectives examined the pharmacist's role in HIV care in this country.
Sep 10, 2020
0
1
(HealthDay)—From 2014 to 2018, there were increases noted in third-party and out-of-pocket (OOP) payments per 30 tenofovir disoproxil fumarate with emtricitabine (TDF-FTC) tablets for HIV preexposure prophylaxis (PrEP), ...
Sep 09, 2020
0
4
HIV prevention remains a public health priority in the United States. Pre-exposure prophylaxis (PrEP) is a drug regimen recommended for individuals who have engaged in behaviors that place them at elevated risk for HIV. When ...
Sep 09, 2020
0
4
Spearheaded by scientists at The Wistar Institute, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first ...
Sep 08, 2020
0
3
The COVID-19 pandemic tends to conceal other important health issues. One of these is the global target for reducing HIV infections and increasing access to treatment. Progress is well under way. In 2019, 67% of those living ...
Sep 04, 2020
0
4
Truck drivers in sub-Saharan Africa are especially vulnerable to infection with HIV due to contact with multiple sexual partners—often including sex workers—along their trucking routes. Accessing HIV testing can be a ...
Sep 03, 2020
0
4
The observational study involving more than 1,300 people was led by the London School of Hygiene & Tropical Medicine (LSHTM), University of Malawi College of Medicine and colleagues at the University of Cambridge.
Sep 02, 2020
0
4
Antiretroviral therapy (ART) may well have revolutionized our ability to control HIV, but it's not necessarily a panacea.
Sep 02, 2020
0
0
A recent study published in the journal Nature Medicine, led by researchers Todd Allen, Ph.D., a professor of Medicine at Harvard Medical School (HMS) and group leader at the Ragon Institute of MGH, MIT and Harvard, and Jim ...
Aug 31, 2020
0
60
People with HIV from BAME communities, women and heterosexual men are underrepresented in HIV studies—according to new research from the University of East Anglia and Western Sydney University.
Aug 27, 2020
0
4
Xu Yu, MD, Ragon group leader, recently published a study entitled "Distinct viral reservoirs in individuals with spontaneous control of HIV-1," in Nature. Yu's lab, in collaboration with Ragon group leaders Mathias Lichterfeld, ...
Aug 26, 2020
0
43
Scientists have developed an injectable drug that blocks HIV from entering cells. They say the new drug potentially offers long-lasting protection from the infection with fewer side effects. The drug, which was tested in ...
Aug 21, 2020
1
293
The UNAIDS estimates that 38 million people currently live with human immunodeficiency virus (HIV) infection. Combination antiretroviral treatment has had great success in saving lives but is also associated with numerous ...
Aug 19, 2020
0
5
An immunomodulatory drug called fingolimod, which is approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and transmission in human immune cells, according to a study published ...
Aug 13, 2020
0
47
